![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Has the outlook for patients with multiple myeloma changed in recent years? Not much. This paper compares 81 patients followed from 1954 to 1960 with 61 patients seen from 1960 to 1967. Most of the first group received urethane, while later patients were given such agents as melphalan and cyclophosphamide. Although more patients temporarily improved on newer drugs, survival rates stayed about the same.